research

The Use of Recombinant Activated FVII (rFVIIa, Novoseven) in the Treatment of a Lifethreatening Retroperitoneal Hemorrhage in a Hemophilia A Patient with Inhibitors to FVIII

Authors
Publication date
1 January 2000
Publisher
Serviço de Imuno-Hemoterapia do Hospital de S. José

Abstract

Abstract is not available.

    Similar works

    Full text

    thumbnail-image

    Available Versions

    Repository of the Hospital Center of Central Lisbon

    redirect
    oaioai:repositorio.chlc.min-saude...
    Last time updated on 17/04/2020

    Repositório do Centro Hospitalar de Lisboa Central, EPE

    redirect
    oaioai:repositorio.chlc.min-saude...
    Last time updated on 29/11/2016